Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Paula E. Keating"'
Publikováno v:
Pathology. 54:129-131
Autor:
Barry D. Hock, Shwan Karim, Michael Schultz, Lisa K. Stamp, Esther T. Johanna Helms, Paula E. Keating, Murray L. Barclay
Publikováno v:
Internal Medicine Journal. 49:513-518
BACKGROUND Therapeutic drug monitoring of anti-tumour necrosis factor (TNF) drugs and anti-drug antibodies (ADA) is now recommended in the treatment of inflammatory bowel disease. However, assay types and drug concentration thresholds are still debat
Autor:
Stewart M. Smith, Barry D. Hock, Christopher J McEntyre, Judith L. McKenzie, Paula E. Keating, Liping Goddard
Publikováno v:
Therapeutic Drug Monitoring. 40:705-715
The measurement of anti-drug antibody (ADA) levels in adalimumab (ADAL)-treated and infliximab (IFX)-treated patients is critical for guiding therapeutic strategies. The homogeneous mobility shift assay (HMSA) and affinity capture elution (ACE) assay
Publikováno v:
Therapeutic drug monitoring. 43(1)
Autor:
John L. O'Donnell, Mark van Voorthuizen, Caroline Allan, Myfanwy Spellerberg, Paula E. Keating
Publikováno v:
Pathology. 53(6)
Publikováno v:
Pathology. 52:373-374
Publikováno v:
Pathology. 52(3)
Publikováno v:
Internal Medicine Journal. 46:622-625
Statins are one of the most commonly prescribed drugs in New Zealand, with 525 772 or 16.5% of the adult New Zealand population prescribed a statin between June 2013 and July 2014. While generally well-tolerated, statins are known to cause a range of
Autor:
John L. O'Donnell, Stewart M. Smith, Caroline Allan, Ignatius Chua, Myfanwy Spellerberg, Paula E. Keating
Publikováno v:
Pathology. 51:S128-S129
Autor:
J Liu, John L. O'Donnell, M Spellerberg, E Gumbley, A Soepnel, Ignatius Chua, M van Voorthuizen, Paula E. Keating
Publikováno v:
Poster Presentations.
Background Idiopathic inflammatory myopathies can be classified by clinicopathological phenotype into four major groups: overlap myositis (OM), dermatomyositis (DM), immune mediated necrotising myositis (IMMNM) and inclusion body myositis (IBM). The